Category Archives: Prostate cancer

No Mortality Benefit Seen from PSA Screening


Image via Wikipedia No Mortality Benefit Seen from PSA Screening By Charles Bankhead, Staff Writer, MedPage TodayPublished: January 06, 2012Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco. Prostate cancer screening with prostate-specific antigen (PSA) afforded no … Continue reading

Posted in Augmenix, GlaxoSmithKline, Journal of the National Cancer Institute, Ortho Clinical Diagnostics, Prostate cancer, Prostate cancer screening, Prostate-specific antigen, psa | Leave a comment

Contraceptive pill associated with increased prostate cancer risk worldwide


Image via Wikipedia ABSTRACTBackground: Several recent studies have suggested that oestrogen exposure may increase the risk of prostate cancer (PCa).Objectives: To examine associations between PCa incidence and mortality and population-based use of oral contraceptives (OCs). It was hypothesised that OC … Continue reading

Posted in Birth control, BMJ, Cancer, Estrogen, Incidence (epidemiology), International Agency for Research on Cancer, Prostate cancer, United Nations | Leave a comment

PSA and prostate cancer


Image via Wikipedia Draft Recommendation Statement The U.S. Preventive Services Task Force will be accepting comments on this draft recommendation statement beginning on Tuesday, October 11, 2011. The U.S. Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of … Continue reading

Posted in Cancer, Prostate, Prostate cancer, Prostate cancer screening, psa, Task Force, United States, United States Preventive Services Task Force | Leave a comment

PSA & New York Times


Healthy men should no longer receive a P.S.A. blood test to screen forprostate cancer because the test does not save lives over all and often leads to more tests and treatments that needlessly cause pain,impotence and incontinence in many, a key government health panel … Continue reading

Posted in Blood test, Cancer, Cancer screening, Health, New York Times, Prostate, Prostate cancer, Prostate cancer screening, psa | Leave a comment

Cribado de cancer de prostata – Screening of prostaste cancer


Image via Wikipedia Editorial del NEJM 26 de Marzo 2009In the United States, most men over the age of 50 years have had a prostate-specific–antigen (PSA) test,1 despite the absence of evidence from large, randomized trials of a net benefit. … Continue reading

Posted in Cancer, cribado, NEJM, Prevencion, Prostata, Prostate, Prostate cancer, Prostate cancer screening, Prostate-specific antigen, psa, Rectal examination, screening, United States | Leave a comment

New drugs for prostate cancer


Image via CrunchBase By ANDREW POLLACK Published: June 27, 2011 Enlarge This Image A group of new drugs is promising to prolong the lives and relieve the symptoms of men with advanced prostate cancer, but could also add billions of dollars to … Continue reading

Posted in Cancer, Conditions and Diseases, finasteride, Genitourinary, Harvard School of Public Health, Health, Prostate, Prostate cancer | Leave a comment

El cribado del cancer de prostata no se asocia a una disminucion de la mortalidad


                              Image via WikipediaConcato J, Wells CK, Horwitz RI, Penson D, Fincke G, Berlowitz DR, et al. The Effectiveness of Screening for Prostate Cancer: A Nested … Continue reading

Posted in AP al dia, Cancer, Conditions and Diseases, cribado, Health, Hectare, mortalidad, NEJM, Prostata, Prostate cancer, screening | Leave a comment

5-alpha reductase inhibitors (5-ARIs): Label Change – Increased Risk of Prostate Cancer


5-alpha reductase inhibitors (5-ARIs): Label Change – Increased Risk of Prostate Cancer Drugs in the 5-ARI class include finasteride and dutasteride. These drugs are marketed under the brand-names Proscar, Propecia, Avodart, and Jalyn AUDIENCE: Urology, Family Medicine, Internal Medicine ISSUE: … Continue reading

Posted in 5-alpha-reductase inhibitor, Benign prostatic hyperplasia, Cancer, Dutasteride, finasteride, Food and Drug Administration, Prostate, Prostate cancer | Leave a comment